Loading stock data…
Claritev Corporation (CTEV)
$33.82+0.67 (+2.02%)
After Hours$33.82+0.00 (+0.00%)· Last close Jun 29
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Claritev Corporation in the Healthcare sector is trading at $33.82 with a market capitalization of $521M. Wall Street consensus targets $36.83 (6 analysts), implying a +8.9% move over the next 12 months. The stock is currently 54% below its 52-week high of $74.07, remaining 1.6% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +8.9% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $244.68M↓ | $246.55M↑ | $245.96M↑ | $241.57M↑ | $231.33M |
| Gross Profit | $163.87M↓ | $168.52M↑ | $163.65M↑ | $162.44M↑ | $154.13M |
| Operating Income | $6.68M↓ | $8.67M↓ | $10.07M↓ | $16.58M↑ | $13.41M |
| Net Income | -$73.56M↑ | -$80.57M↓ | -$69.75M↓ | -$62.64M↑ | -$71.32M |
Peer Comparison
JNJUNHPFE
Fundamentals
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers claims intel...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$521.49M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
118.82%
Volume
Today's trading volume
145,220
Recent News
Strength Seen in Evolent Health (EVH): Can Its 9.5% Jump Turn into More Strength?
Evolent Health (EVH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Claritev (CTEV) Stock Faces Mixed Analyst Target Changes As Growth Execution Questions Build
The latest reset in Claritev’s average price target to US$61 from levels near US$90 is putting fresh attention on how the stock’s valuation is being recalibrated. Analysts link this shift to a more cautious stance around Claritev’s execution on growth initiatives, even as some highlight new contracts, coverage initiations, and management changes as potential supports. In the sections ahead, you will see how to track these moving pieces and what to watch as the narrative around Claritev...
How The Claritev (CTEV) Investment Story Is Evolving As The Market Holds Its Fair Value View
Claritev’s latest analyst update keeps the price target unchanged, signaling that current expectations remain steady based on available information. With no new analyst commentary provided, the focus stays on how existing views continue to shape the stock’s story. As you read on, you will see how to track these kinds of shifts in the narrative so you can stay aligned with what the market is watching. Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies...
Sector Update: Healthcare Stocks Advance Late Afternoon
Healthcare stocks rose late Monday afternoon, with the NYSE Healthcare Index and the State Street He
Sector Update: Healthcare Stocks Advance Monday Afternoon
Healthcare stocks rose Monday afternoon, with the NYSE Healthcare Index adding 0.4% and the State St